The Effect of Serum Oxytocin Levels on Vitamin D, Body Mass Index, Lipid Profile, Metabolic and Biochemical Parameters in Children: A Prospective Study

Abstract

Objective: Oxytocin plays a significant role in the regulation of carbohydrate and lipid metabolism and has been suggested to be associated with obesity and components of metabolic syndrome (MetS). This prospective study aimed to investigate the relationship between serum oxytocin levels and vitamin D status, body mass index (BMI), lipid profile, and various metabolic and biochemical parameters in the pediatric population. Methods: A total of 87 children, who presented for routine follow-up, were enrolled in this prospective study. Anthropometric measurements, serum oxytocin levels and comprehensive laboratory parameters were evaluated. Results: No statistically significant correlations were observed between oxytocin level and patient age, weight, height, body mass index (BMI), or their respective percentiles. Furthermore, oxytocin showed no significant associations with the evaluated laboratory parameters. Notably, a significant inverse correlation was detected between oxytocin and 25-hydroxyvitamin D (25OHD) concentrations, whereby oxytocin levels decreased as 25OHD levels increased (p = 0.001). Conclusions: This study demonstrated that, unlike findings reported in adult populations, oxytocin levels were not significantly associated with BMI, lipid profile, or other metabolic parameters in healthy children. Moreover, this is the first study to report that oxytocin levels are significantly elevated in children with vitamin D deficiency.

Keywords

• Child
• Metabolic
• Lipid profile
• Oxytocin
• Vitamin D

References

1. Blevins JE, Graham JL, Morton GJ, Bales KL, Schwartz MW, Baskin DG, et al. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. Am J Physiol Regul Integr Comp Physiol. 2015;308(5):R431-8. doi:10.1152/ajpregu.00441.2014.
2. Kerem L, Lawson EA. The effects of oxytocin on appetite regulation, food intake and metabolism in humans. Int J Mol Sci. 2021;22(14):7737. doi:10.3390/ijms22147737.
3. Blevins JE, Ho JM. Role of oxytocin signaling in the regulation of body weight. Rev Endocr Metab Disord. 2013;14(4):311-29. doi:10.1007/s11154-013-9260-x.
4. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157(8):821-7. doi:10.1001/archpedi.157.8.821.
5. Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, Bas F. Growth references for Turkish children aged 6 to 18 years [published correction appears in Acta Paediatr. 2007 Feb;96(2):324]. Acta Paediatr. 2006;95(12):35-41. doi:10.1080/08035250600652013.
6. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents [published correction appears in Pediatrics. 2017 Dec;140(6):e20173035. doi:10.1542/peds.2017-3035.] [published correction appears in Pediatrics. 2018 Sep;142(3):e20181739. doi:10.1542/peds.2018-1739]. Pediatrics. 2017;140(3):e20171904. doi:10.1542/peds.2017-1904.
7. Liu CM, Spaulding MO, Rea JJ, Noble EE, Kanoski SE. Oxytocin and food intake control: neural, behavioral, and signaling mechanisms. Int J Mol Sci. 2021;22(19):10859. doi:10.3390/ijms221910859.
8. Abraham TM, Massaro JM, Hoffmann U, Yanovski JA, Fox CS. Metabolic characterization of adults with binge eating in the general population: the Framingham Heart Study. Obesity (Silver Spring). 2014;22(11):2441-9. doi:10.1002/oby.20867.

9. Weingarten MFJ, Scholz M, Wohland T, Horn K, Stumvoll M, Kovacs P, et al. Circulating oxytocin is genetically determined and associated with obesity and impaired glucose tolerance. J Clin Endocrinol Metab. 2019;104(11):5621-32. doi:10.1210/jc.2019-00643.
10. Szulc P, Amri EZ, Varennes A, Panaia-Ferrari P, Fontas E, Goudable J, et al. High serum oxytocin is associated with metabolic syndrome in older men - The MINOS study. Diabetes Res Clin Pract. 2016;122:17-27. doi:10.1016/j.diabres.2016.09.022.
11. Qian W, Zhu T, Tang B, Yu S, Hu H, Sun W, et al. Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients. J Clin Endocrinol Metab. 2014;99(12):4683-9. doi:10.1210/jc.2014-2206.
12. Fu-Man D, Hong-Yu K, Bin-Hong D, Da-Na L, Xin-Yang Y. Associations of oxytocin with metabolic parameters in obese women of childbearing age. Endokrynol Pol. 2019;70(5):417-22. doi:10.5603/EP.a2019.0028.
13. Valette M, Diene G, Glattard M, Cortadellas J, Molinas C, Faye S, et al. Early oxytocin treatment in infants with Prader-Willi syndrome is safe and is associated with better endocrine, metabolic and behavioral outcomes. Orphanet J Rare Dis. 2025;20(1):96. doi:10.1186/s13023-025-03560-3.
14. Espinoza SE, Lee JL, Wang CP, Ganapathy V, MacCarthy D, Pascucci C, et al. Intranasal oxytocin ımproves lean muscle mass and lowers LDL cholesterol in older adults with sarcopenic obesity: a pilot randomized controlled trial. J Am Med Dir Assoc. 2021;22(9):1877-1882.e2. doi:10.1016/j.jamda.2021.04.015.
15. Mekki LB, Elhassan YH, Badi RM, Shazali AF, Mojaddidi MA, Ibrahim S, et al. Elevated oxytocin levels and their relationship to metabolic syndrome and obesity among young sudanese adults: a cross-sectional analysis. Cureus. 2025;17(3):e81451. doi:10.7759/cureus.81451.
16. Binay Ç, Paketçi C, Güzel S, Samancı N. Serum irisin and oxytocin levels as predictors of metabolic parameters in obese children. J Clin Res Pediatr Endocrinol. 2017;9(2):124-31. doi:10.4274/jcrpe.3963.
17. Elabd C, Cousin W, Upadhyayula P, Chen RY, Chooljian MS, Li J, et al. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat Commun. 2014;5:4082. doi:10.1038/ncomms5082.
18. Mens WB, Witter A, Greidanus TBVW. Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain research, 1983;262(1):143-9. doi:10.1016/0006-8993(83)90478-X.
19. Franke AA, Li X, Dabalos C, Lai JF. Improved oxytocin analysis from human serum and urine by orbitrap ESI-LC-HRAM-MS. Drug Test Anal. 2020;12(6):846-52. doi:10.1002/dta.2783.
20. Kaviani M, Nikooyeh B, Zand H, Yaghmaei P, Neyestani TR. Effects of vitamin D supplementation on depression and some involved neurotransmitters. J Affect Disord. 2020;269:28-35. doi:10.1016/j.jad.2020.03.029.
21. Melguizo-Rodríguez L, Costela-Ruiz VJ, García-Recio E, De Luna-Bertos E, Ruiz C, Illescas-Montes R. Role of vitamin D in the metabolic syndrome. Nutrients. 2021;13(3):830. doi:10.3390/nu13030830.